AI-Driven Discovery Pipeline Identifies Carvedilol as a Novel Partial Agonist of THRβ
Thyroid hormone receptor beta (THRβ) is a key therapeutic target for metabolic dysfunction-associated steatotic liver disease and dyslipidemia, yet the discovery of structurally diverse agonists remains challenging. Here, we developed an AI-driven hierarchical drug discovery framework integrating graph neural network...